Results 191 to 200 of about 108,375,652 (210)

Nonpeptide Tachykinin Receptor Antagonists: I. Pharmacological and Pharmacokinetic Characterization of SB 223412, a Novel, Potent and Selective Neurokinin-3 Receptor Antagonist

Journal of Pharmacology and Experimental Therapeutics, 1997
Nabil A Elshourbagy, Douglas W P Hay, H M Sarau   +2 more
exaly  

Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

New England Journal of Medicine, 1999
Richard J Gralla, Paul J Hesketh
exaly  

Neurokinin 3 Receptor Antagonist Revival Heats Up With Astellas Acquisition

Nature Reviews Drug Discovery, 2017
Megan Cully
exaly  

Prevention of cisplatin-induced emesis by a neurokinin-1-receptor antagonist.

The New England journal of medicine, 1999
F, Roila, E, Ballatori, A, Del Favero
openaire   +2 more sources

Fosaprepitant (MK-0517): A Neurokinin-1 Receptor Antagonist for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Expert Opinion on Investigational Drugs, 2007

exaly  

Antidepressant-Like Effects of Neurokinin Receptor Antagonists in the Forced Swim Test in the Rat

European Journal of Pharmacology, 2005
James L Henry
exaly  

Neurokinin Receptor Antagonists

Expert Opinion on Investigational Drugs, 2000
exaly  

A Multicenter, Double-Blind, Randomized, Placebo Controlled Trial of a Neurokinin-1 Receptor Antagonist for Overactive Bladder

Journal of Urology, 2010
exaly  

The Triple Neurokinin-Receptor Antagonist CS-003 Inhibits Neurokinin A-Induced Bronchoconstriction in Patients With Asthma

Pulmonary Pharmacology and Therapeutics, 2006
Guy F Joos, Renaud Louis, R Pauwels
exaly  

Fosaprepitant: A Neurokinin-1 Receptor Antagonist for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Expert Review of Anticancer Therapy, 2008

exaly